Predict your next investment

Merchant Bank
FINANCE | Investment Banking
iroquoiscg.com

See what CB Insights has to offer

Investments

408

Portfolio Exits

124

Funds

1

About Iroquois Capital Group

Iroquois Capital Group is a merchant banking and investment banking company led by business executives who have been CEOs, owners, and operators of businesses, with extensive finance and mergers and acquisitions experience. The Company works primarily with companies in the health care and financial services industries – and often invests their own capital and the capital of their individual investors in these companies – to provide highly selective alternative investment opportunities to high net worth individuals.

Iroquois Capital Group Headquarter Location

401 Commerce Street Suite 740

Nashville, Tennessee, 37219,

United States

615-467-7200

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Iroquois Capital Group Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Iroquois Capital Group Rank

Latest Iroquois Capital Group News

KKR To Acquire Covenant Surgical Partners

Aug 9, 2017

KKR To Acquire Covenant Surgical Partners NASHVILLE, Tenn., August 8, 2017-- Covenant Surgical Partners, Inc. (“Covenant”) announced today that KKR is acquiring Covenant from DFW Capital Partners, Iroquois Capital Group, PineBridge Investments, and other existing shareholders. Financial details of the transaction were not disclosed. Covenant is a leading acquirer and operator of ambulatory surgery centers (“ASCs”) and physician practices. The Company currently provides gastrointestinal and ophthalmic procedures through 37 ASC and physician practice locations across 17 states. Covenant works in partnership with its affiliated physicians to provide value added financial, operational, and ancillary services to enhance business and clinical operations. “This transaction marks the next stage of Covenant’s evolution,” said Lew Little, Chief Executive Officer of Covenant. “This is the second time I’ve had the opportunity to work with KKR. Having seen firsthand what their partnership and resources can contribute to a company, I am thrilled to welcome them to the Covenant family and together accelerate our future growth.” “Covenant provides an important role in improving patient access and reducing costs for the health care system. We look forward to partnering with Covenant in building a premier professional services organization to support its affiliated surgery centers and physician practices,” said Jim Momtazee, Head of KKR’s Health Care investment team. “It has been a privilege to partner with the Covenant team in building one of the premier ambulatory surgery platforms and physician services companies in the nation,” said Keith Pennell, Managing Partner at DFW Capital Partners. The transaction, which is subject to regulatory approvals and other customary closing conditions, is expected to close in the third quarter of 2017. KKR is making its investment primarily through its KKR Americas XII Fund. Piper Jaffray & Co. acted as exclusive financial advisor and Ice Miller LLP acted as legal advisor to Covenant. Simpson Thacher & Bartlett LLP served as legal counsel to KKR. Fully committed debt financing will be provided by Goldman Sachs and KKR Capital Markets. About Covenant Surgical Partners Headquartered in Nashville, TN, Covenant Surgical Partners is a leading acquirer and operator of ambulatory surgery centers and physician practices with 37 facilities located across 17 states. Covenant partners with its affiliated physicians to deliver high quality and cost effective solutions for patient care. For more information, please visit www.covenantsp.com. About KKR KKR is a leading global investment firm that manages multiple alternative asset classes, including private equity, energy, infrastructure, real estate, credit and, through its strategic partners, hedge funds. KKR aims to generate attractive investment returns by following a patient and disciplined investment approach, employing world-class people, and driving growth and value creation with KKR portfolio companies. KKR invests its own capital alongside its partners' capital and provides financing solutions and investment opportunities through its capital markets business. References to KKR’s investments may include the activities of its sponsored funds. For additional information about KKR & Co. L.P. (NYSE: KKR), please visit KKR's website at www.kkr.com and on Twitter @KKR_Co. Contact:

Iroquois Capital Group Investments

408 Investments

Iroquois Capital Group has made 408 investments. Their latest investment was in Cimarron Acid Services as part of their Mezzanine on February 2, 2014.

CBI Logo

Iroquois Capital Group Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

2/1/2014

Mezzanine

Cimarron Acid Services

No

2

12/31/2013

Line of Credit - V

Covenant Surgical Partners

$95M

No

1

9/1/2013

Debt

Cimarron Acid Services

Yes

1

2/5/2013

Series C

Subscribe to see more

$99M

Subscribe to see more

10

1/1/2013

Debt

Subscribe to see more

Subscribe to see more

10

Date

2/1/2014

12/31/2013

9/1/2013

2/5/2013

1/1/2013

Round

Mezzanine

Line of Credit - V

Debt

Series C

Debt

Company

Cimarron Acid Services

Covenant Surgical Partners

Cimarron Acid Services

Subscribe to see more

Subscribe to see more

Amount

$95M

$99M

New?

No

No

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

2

1

1

10

10

Iroquois Capital Group Portfolio Exits

124 Portfolio Exits

Iroquois Capital Group has 124 portfolio exits. Their latest portfolio exit was Caladrius Biosciences on April 27, 2022.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

4/27/2022

Acq - Pending

4

4/13/2022

Acq - Pending

$99M

4

11/16/2020

Acq - P2P

$99M

3

10/23/2020

Acq - P2P

Subscribe to see more

$99M

Subscribe to see more

10

8/28/2020

Take Private

Subscribe to see more

$99M

Subscribe to see more

10

Date

4/27/2022

4/13/2022

11/16/2020

10/23/2020

8/28/2020

Exit

Acq - Pending

Acq - Pending

Acq - P2P

Acq - P2P

Take Private

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Sources

4

4

3

10

10

Iroquois Capital Group Acquisitions

2 Acquisitions

Iroquois Capital Group acquired 2 companies. Their latest acquisition was Tigrent on December 08, 2005.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

12/8/2005

Other Venture Capital

$99M

$7.88M

Acquired

12/10/2004

Subscribe to see more

$99M

Subscribe to see more

0

Date

12/8/2005

12/10/2004

Investment Stage

Other Venture Capital

Companies

Subscribe to see more

Valuation

$99M

$99M

Total Funding

$7.88M

Note

Acquired

Subscribe to see more

Sources

0

Iroquois Capital Group Fund History

1 Fund History

Iroquois Capital Group has 1 fund, including Iroquois Capital Group Investment Fund.

Closing Date

Fund

Fund Type

Status

Amount

Sources

Iroquois Capital Group Investment Fund

$13.25M

2

Closing Date

Fund

Iroquois Capital Group Investment Fund

Fund Type

Status

Amount

$13.25M

Sources

2

Iroquois Capital Group Team

2 Team Members

Iroquois Capital Group has 2 team members, including current Chief Executive Officer, President, Bill McGugin.

Name

Work History

Title

Status

Bill McGugin

Covenant Capital

Chief Executive Officer, President

Current

Maggie Barnhart

Chief Compliance Officer, Senior Vice President

Current

Name

Bill McGugin

Maggie Barnhart

Work History

Covenant Capital

Title

Chief Executive Officer, President

Chief Compliance Officer, Senior Vice President

Status

Current

Current

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.